Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Higher IGF-1 levels in hair follicles link to better finasteride results for hair loss.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Effective acne treatments should reduce sebum, bacteria, and inflammation, with isotretinoin being the best for severe cases.

Advances in mechanobiology and immunology could lead to scarless wound healing.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

General anesthesia might be linked to certain types of hair loss, but more research is needed.

New findings suggest the protein linked to Birt–Hogg–Dubé syndrome is important in cell signaling and could affect treatment understanding.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Amyloid proteins can cause rare hair loss by depositing in the scalp.

FMF and mycosis fungoides are variants of the same disease, and bexarotene can be an effective treatment.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

A Rathke's cleft cyst caused hormonal imbalances and symptoms in a 68-year-old woman.

Topical minoxidil does not change the activity of hair follicle enzymes that metabolize it.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

PRP injections increased hair density in men with hair loss but didn't work for everyone and more research is needed.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Spaceflight can harm skin health by altering gene expression, affecting DNA, mitochondria, and skin barriers.

Bacteria can help skin regenerate through a process called IL-1β signaling.

Propranolol can cause reversible hair loss.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Current treatments for common male hair loss have limited effectiveness and can cause side effects.